Trial intelligence / Profile preview

Exenatide effect on brown adipose tissue and energy expenditure in healthy young men

2016-000238-23Phase 4Completed

Sponsor
Leiden University Medical Center
Start
Jul 2016
Modality
Peptides
Countries
1
01

Overview

Phase 4 trial of exenatide in obesity and dyslipidemia, sponsored by Leiden University Medical Center. Primary endpoint: Primary - BAT volume and activity. Started Jul 2016; status: completed.

02

Drugs

exenatide
03

Conditions

obesitydyslipidemia

Beyond the preview

Go deeper on 2016-000238-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-000238-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call